July 16, 2025
Intangible Assets

How Regeneron is using patent tactics to try to thwart competition

A court battle between two of the nation’s largest biotechs — Regeneron Pharmaceuticals and Amgen — is testing the legal limits of how far drugmakers can go in using patents to thwart competition. And the case is being closely watched by companies that sell biosimilar medicines amid concerns that the U.S. patent system is being

Read More
Intangible Assets

HMEL secures three Indian patents including global-first tech for crude and naphtha co-transport, ET EnergyWorld

New Delhi: HPCL-Mittal Energy Limited (HMEL) has been granted three Indian patents, including two that introduce what the company claims to be the world’s first design for pipeline pigs enabling the simultaneous transportation of naphtha in crude pipelines. With these additions, HMEL’s total number of granted patents stands at nine, out of over 44 filed

Read More
Intangible Assets

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Includes Conduit’s first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 and AZD5658Patents derived from AI-led analysis conducted in partnership with Sarborg Limited NAPLES, Fla. and CAMBRIDGE, United Kingdom, July 07, 2025 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”) today announces the filing of

Read More
Intangible Assets

Mint Primer | How a $12 bn R&D scheme could change the way India makes technology

How will the government’s scheme work? With a net outlay of $12 billion ( ₹1 trillion) spread over multiple years, the scheme to finance the R&D budgets of companies will operate under the Anusandhan National Research Foundation (ANRF) of the Department of Science and Technology. Through a ‘special purpose fund’ within ANRF, the Centre will

Read More
Intangible Assets

Acesis Biomed Secures Patents Advancing Testosterone-Inducing Drug Development

Company milestone aligns with June’s Men’s Health Month and ongoing capital raising initiative Centennial, Colorado, June 30, 2025 (GLOBE NEWSWIRE) — Acesis Holdings Corporation (“Acesis Biomed”), a pre-clinical stage biomedical company pioneering oral treatments for metabolic and endocrine disorders linked to low testosterone, today announced a meaningful expansion of its intellectual property portfolio with the  granting

Read More
Intangible Assets

Cre8tive Technology and Design Patents ERP Compliance Solution, Expands Globally with Strategic Partner Precise

Cre8tive’s Advanced ERP Meets Rising Demand from Global Defense Industrial Base SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) — Cre8tive Technology and Design (Cre8tive), the leading provider of manufacturing technology solutions, has announced its patent-pending ERP Compliance Solution for aerospace, defense, and government contracting is now available globally. This milestone significantly advances its international growth

Read More
Intangible Assets

AeroFlexx Awarded New Patents in Sustainable Packaging Innovation

The company continues its commitment to offering a leading sustainable liquid packaging solution WEST CHESTER, Ohio, June 02, 2025 (GLOBE NEWSWIRE) — AeroFlexx, a leader in sustainable packaging, has been awarded U.S. Patents 11,548,709 and 12,071,292. These patents present a flexible plastic package suitable for curbside recycling where all plastic bottles are accepted* that aligns

Read More
Intangible Assets

ParkerVision Responds to Court Ruling in Long-Running Patent Case Against Qualcomm

Company Believes Ruling Conflicts with Higher Court Guidance JACKSONVILLE, FL / ACCESS Newswire / June 2, 2025 / ParkerVision, Inc. (OTCQB:PRKR), a leader in wireless radio-frequency (RF) innovation, today issued a statement in response to a recent claim construction ruling from the U.S. District Court for the Middle District of Florida in its over 11-year

Read More
Intangible Assets

Moleculin Bolsters Annamycin Intellectual Property Portfolio with Granting of Two New U.S. Patents

Company continues to expand global IP coverage and claims to major markets, now extending to June 2040  HOUSTON, May 05, 2025 (GLOBE NEWSWIRE) — Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers and viruses, today announced the U.S. Patent and

Read More
Intangible Assets

In 2024-25, IIT Madras filed 417 patents, doubling licencing revenue

Indian Institute of Technology (IIT) Madras. File | Photo Credit: B. Velankanni Raj The Indian Institute of Technology (IIT) Madras has filed 417 patents in 2024-25, including 298 Indian patents and 119 international patents. The institute has filed 39 designs, six copyrights, and one trademark, bringing the total number of IP filings to 463. This

Read More